This inventor holds 1 USPTO granted patent. Top assignees: Mineralys Therapeutics, Inc., Tanabe Pharma Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 7 Years Active: 2026
Title: Fuminori Ozaki: Pharmaceutical Invention and Patent
Introduction
Fuminori Ozaki is an inventor associated with Osaka, Japan. His patent work includes a pharmaceutical composition designed to preserve the properties of a salt used in a disubstituted 1,2,4-triazine compound.
Latest Patents
Ozaki is named on one patent, titled “Soluble Pharmaceutical Compositions Comprising Salts of Disubstituted 1,2,4-Triazine Compound.” The patent describes pharmaceutical compositions containing a salt of a specified compound and one or more excipients. The composition is designed to avoid inducing disproportionation of the compound’s salt. Ozaki’s record includes 1 patent.
Career Highlights
Ozaki’s professional affiliations include Mineralys Therapeutics, Inc. and Tanabe Pharma Corporation. These affiliations connect his career with organizations working in the pharmaceutical sector.
Collaborations
Among Ozaki’s named coworkers are Robert McKean and Roch Thibert. Their inclusion reflects professional connections associated with his work.
Conclusion
Fuminori Ozaki’s patent record highlights an invention focused on soluble pharmaceutical compositions and the stability of a compound’s salt, alongside career affiliations in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile